Search Results

There are 8321 results for: content related to: Cucurbit[7]uril Containers for Targeted Delivery of Oxaliplatin to Cancer Cells

  1. Cucurbit[7]uril Containers for Targeted Delivery of Oxaliplatin to Cancer Cells

    Angewandte Chemie International Edition

    Volume 52, Issue 46, November 11, 2013, Pages: 12033–12037, Dr. Liping Cao, Gaya Hettiarachchi, Prof. Dr. Volker Briken and Prof. Dr. Lyle Isaacs

    Version of Record online : 13 SEP 2013, DOI: 10.1002/anie.201305061

  2. Clinical application of oxaliplatin in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 5, September/October 2006, Pages: 1717–1732, S. FU, J.J. KAVANAGH, W. HU and R.C. BAST Jr

    Version of Record online : 17 JUL 2006, DOI: 10.1111/j.1525-1438.2006.00654.x

  3. You have free access to this content
    Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients

    Cancer

    Volume 118, Issue 12, 15 June 2012, Pages: 3173–3181, C. Daniel Mullins, Fei-Yuan Hsiao, Eberechukwu Onukwugha, Naimish B. Pandya and Nader Hanna

    Version of Record online : 21 OCT 2011, DOI: 10.1002/cncr.26613

  4. Effects of oxaliplatin and oleic acid Gc-protein-derived macrophage-activating factor on murine and human microglia

    Journal of Neuroscience Research

    Volume 93, Issue 9, September 2015, Pages: 1364–1377, Jacopo J.V. Branca, Gabriele Morucci, Francesca Malentacchi, Stefania Gelmini, Marco Ruggiero and Stefania Pacini

    Version of Record online : 18 MAR 2015, DOI: 10.1002/jnr.23588

  5. You have free access to this content
    PKC/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effects

    International Journal of Cancer

    Volume 137, Issue 1, 1 July 2015, Pages: 243–250, Masanobu Tsubaki, Tomoya Takeda, Tadahumi Tani, Hirotaka Shimaoka, Naohiro Suzuyama, Kotaro Sakamoto, Arisa Fujita, Naoki Ogawa, Tatsuki Itoh, Motohiro Imano, Yoshinori Funakami, Seiji Ichida, Takao Satou and Shozo Nishida

    Version of Record online : 8 DEC 2014, DOI: 10.1002/ijc.29367

  6. You have free access to this content
    Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults

    Cancer

    Volume 118, Issue 11, 1 June 2012, Pages: 2925–2934, Christina D. Mack, William Carpenter, Anne-Marie Meyer, Hanna Sanoff and Til Stürmer

    Version of Record online : 9 NOV 2011, DOI: 10.1002/cncr.26622

  7. The role of oxaliplatin in the management of upper gastrointestinal tract malignancies

    Colorectal Disease

    Volume 5, Issue s3, November 2003, Pages: 36–44, W. Scheithauer and E. Van Cutsem

    Version of Record online : 30 OCT 2003, DOI: 10.1046/j.1463-1318.5.s3.5.x

  8. Overexpression of cFLIPs inhibits oxaliplatin-mediated apoptosis through enhanced XIAP stability and Akt activation in human renal cancer cells

    Journal of Cellular Biochemistry

    Volume 105, Issue 4, 1 November 2008, Pages: 971–979, Shin Kim, Tae-Jin Lee, Jong-Wook Park and Taeg Kyu Kwon

    Version of Record online : 2 SEP 2008, DOI: 10.1002/jcb.21905

  9. You have full text access to this Open Access content
    Enhanced expression of nuclear factor I/B in oxaliplatin-resistant human cancer cell lines

    Cancer Science

    Volume 102, Issue 2, February 2011, Pages: 382–386, Eiji Kashiwagi, Hiroto Izumi, Yoshihiro Yasuniwa, Ryoko Baba, Yoshiaki Doi, Akihiko Kidani, Tokuzo Arao, Kazuto Nishio, Seiji Naito and Kimitoshi Kohno

    Version of Record online : 19 NOV 2010, DOI: 10.1111/j.1349-7006.2010.01784.x

  10. You have free access to this content
    Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma

    FEBS Letters

    Volume 529, Issue 2-3, October 09, 2002, Pages: 232–236, Isabelle Gourdier, Maguy Del Rio, Laure Crabbé, Laurent Candeil, Virginie Copois, Marc Ychou, Charles Auffray, Pierre Martineau, Nadir Mechti, Yves Pommier and Bernard Pau

    Version of Record online : 11 SEP 2002, DOI: 10.1016/S0014-5793(02)03347-1

  11. Oxaliplatin/5-fluorouracil-based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry

    Asia-Pacific Journal of Clinical Oncology

    Volume 11, Issue 4, December 2015, Pages: 334–342, Young Suk Park, Jiafu Ji, John Raymond Zalcberg, Mostafa El-Serafi, Antonio Buzaid and Marwan Ghosn

    Version of Record online : 15 OCT 2015, DOI: 10.1111/ajco.12409

  12. Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicity in vitro and in vivo

    Clinical and Experimental Pharmacology and Physiology

    Volume 40, Issue 6, June 2013, Pages: 371–378, Virginia Ip, Johnson J Liu and Mark J McKeage

    Version of Record online : 28 MAY 2013, DOI: 10.1111/1440-1681.12088

  13. Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization

    Allergy

    Volume 70, Issue 7, July 2015, Pages: 784–794, E. Alvarez-Cuesta, R. Madrigal-Burgaleta, D. Angel-Pereira, A. Ureña-Tavera, M. Zamora-Verduga, P. Lopez-Gonzalez and M. P. Berges-Gimeno

    Version of Record online : 24 APR 2015, DOI: 10.1111/all.12620

  14. You have full text access to this OnlineOpen article
    Pharmacological comparison of a nonhuman primate and a rat model of oxaliplatin-induced neuropathic cold hypersensitivity

    Pharmacology Research & Perspectives

    Volume 4, Issue 1, February 2016, Yuka Shidahara, Shinya Ogawa, Mari Nakamura, Shingo Nemoto, Yuji Awaga, Miyuki Takashima, Aldric Hama, Akihisa Matsuda and Hiroyuki Takamatsu

    Version of Record online : 8 FEB 2016, DOI: 10.1002/prp2.216

  15. Encapsulation of Drug Molecules by Cucurbiturils: Effects on their Chemical Properties in Aqueous Solution

    Israel Journal of Chemistry

    Volume 51, Issue 5-6, May 2011, Pages: 600–615, Donal H. Macartney

    Version of Record online : 15 APR 2011, DOI: 10.1002/ijch.201100040

  16. Comparative analysis of the mutagenic activity of oxaliplatin and cisplatin in the Hprt gene of CHO cells

    Environmental and Molecular Mutagenesis

    Volume 46, Issue 2, 2005, Pages: 104–115, Maria J. Silva, Paula Costa, Anabela Dias, Marco Valente, Henriqueta Louro and Maria G. Boavida

    Version of Record online : 10 MAY 2005, DOI: 10.1002/em.20138

  17. Efficacy of the GemOx-R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma

    British Journal of Haematology

    Antònia Obrador-Hevia, Margalida Serra-Sitjar, José Rodríguez, Lamiae Belayachi, Leyre Bento, Marta García-Recio, Jose María Sánchez, Priam Villalonga, Antonio Gutiérrez and Silvia Fernández de Mattos

    Version of Record online : 25 MAY 2016, DOI: 10.1111/bjh.14141

  18. Hypersensitivity reactions to oxaliplatin: Can patients be rechallenged?

    Asia-Pacific Journal of Clinical Oncology

    Volume 2, Issue 4, December 2006, Pages: 175–179, Kelly W MOK and David GOLDSTEIN

    Version of Record online : 30 OCT 2006, DOI: 10.1111/j.1743-7563.2006.00066.x

  19. You have full text access to this OnlineOpen article
    Oxaliplatin-induced neurotoxicity involves TRPM8 in the mechanism of acute hypersensitivity to cold sensation

    Brain and Behavior

    Volume 2, Issue 1, January 2012, Pages: 68–73, Toru Kono, Machiko Satomi, Manabu Suno, Norihisa Kimura, Hirotaka Yamazaki, Hiroyuki Furukawa and Kazuo Matsubara

    Version of Record online : 30 JAN 2012, DOI: 10.1002/brb3.34

  20. You have free access to this content
    Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma

    International Journal of Cancer

    Volume 126, Issue 7, 1 April 2010, Pages: 1582–1595, Sung-Chul Lim, Jeong Eun Choi, Ho Sung Kang and Han SI

    Version of Record online : 2 SEP 2009, DOI: 10.1002/ijc.24853